104 related articles for article (PubMed ID: 17405747)
21. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic autoantibody that inhibits fibrin monomer polymerization.
Ghosh S; McEvoy P; McVerry BA
Br J Haematol; 1983 Jan; 53(1):65-72. PubMed ID: 6848127
[TBL] [Abstract][Full Text] [Related]
23. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
24. Fibrinopeptides A and B release in the process of surface fibrin formation.
Riedel T; Suttnar J; Brynda E; Houska M; Medved L; Dyr JE
Blood; 2011 Feb; 117(5):1700-6. PubMed ID: 21106983
[TBL] [Abstract][Full Text] [Related]
25. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
[TBL] [Abstract][Full Text] [Related]
27. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
28. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M
Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828
[TBL] [Abstract][Full Text] [Related]
29. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod.
Shen LL; Hermans J; McDonagh J; McDonagh RP
Am J Physiol; 1977 Jun; 232(6):H629-33. PubMed ID: 879301
[TBL] [Abstract][Full Text] [Related]
30. A hereditary dysfibrinogenemia: fibrinogen Awaji.
Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
Bilezikian SB; Nossel HL; Butler VP; Canfield RE
J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
[TBL] [Abstract][Full Text] [Related]
32. Fibrinogen Baltimore II: congenital hypodysfibrinogenemia with delayed release of fibrinopeptide B and decreased rate of fibrinogen synthesis.
Ebert RF; Bell WR
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7318-22. PubMed ID: 6580646
[TBL] [Abstract][Full Text] [Related]
33. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
34. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous antithrombin in a patient with benign paraprotein.
Gabriel DA; Carr ME; Cook L; Roberts HR
Am J Hematol; 1987 May; 25(1):85-93. PubMed ID: 3578266
[TBL] [Abstract][Full Text] [Related]
36. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
Francis CW; Bunce LA; Sporn LA
Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
[TBL] [Abstract][Full Text] [Related]
37. A kinetic model for the alpha-thrombin-catalyzed conversion of plasma levels of fibrinogen to fibrin in the presence of antithrombin III.
Naski MC; Shafer JA
J Biol Chem; 1991 Jul; 266(20):13003-10. PubMed ID: 2071587
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.
Pechik I; Yakovlev S; Mosesson MW; Gilliland GL; Medved L
Biochemistry; 2006 Mar; 45(11):3588-97. PubMed ID: 16533041
[TBL] [Abstract][Full Text] [Related]
39. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
Gralnick HR; Givelber HM; Shainoff JR; Finlayson JS
J Clin Invest; 1971 Sep; 50(9):1819-30. PubMed ID: 5564389
[TBL] [Abstract][Full Text] [Related]
40. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
